Wilcox JA, Ramakrishna R, Magge R.
2018.
Immunotherapy in Glioblastoma.. World Neurosurg. 116:518-528.
Zhang S, Chiang GChia-Yi, Knapp JMarion, Zecca CM, He D, Ramakrishna R, Magge RS, Pisapia DJ, Fine HAlan, Tsiouris AJohn et al..
2020.
Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping.. J Neuroradiol. 47(4):272-277.
Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH et al..
2019.
Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.. J Neuroimaging. 29(5):650-656.
Mahase SS, O'Brien DARoth, No D, Roytman M, Skafida ME, Lin E, Karakatsanis NA, Osborne JR, Brandmaier A, Pannullo SC et al..
2021.
[Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas.. Neurooncol Adv. 3(1):vdab012.
Trifiletti DM, Ruiz-Garcia H, Quinones-Hinojosa A, Ramakrishna R, Sheehan JP.
2021.
The evolution of stereotactic radiosurgery in neurosurgical practice.. J Neurooncol. 151(3):451-459.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chidambaram S, Pannullo SC, Roytman M, Pisapia DJ, Liechty B, Magge RS, Ramakrishna R, Stieg PE, Schwartz TH, Ivanidze J.
2019.
Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.. Neurosurg Focus. 46(6):E10.
Ivanidze J, Roytman M, Skafida M, Kim S, Glynn S, Osborne JR, Pannullo SC, Nehmeh S, Ramakrishna R, Schwartz TH et al..
2022.
Dynamic 68Ga-DOTATATE PET/MRI in the Diagnosis and Management of Intracranial Meningiomas.. Radiol Imaging Cancer. 4(2):e210067.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
Bander ED, Sherman JH, Bettegowda C, Aghi MK, Sheehan J, Ramakrishna R.
2021.
Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons.. J Neurooncol. 151(3):361-366.
Bander ED, Magge R, Ramakrishna R.
2018.
Advances in Glioblastoma Operative Techniques.. World Neurosurg. 116:529-538.